<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-M83FZ8S0</identifier><date>2024</date><creator>Juretič, Andrej</creator><relation>documents/doc/M/URN_NBN_SI_doc-M83FZ8S0_001.pdf</relation><relation>documents/doc/M/URN_NBN_SI_doc-M83FZ8S0_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 37-40</format><identifier identifier_type="ISSN">0353-3484</identifier><identifier identifier_type="DOI">10.61300/angg88</identifier><identifier identifier_type="COBISSID">223908611</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-M83FZ8S0</identifier><language>eng</language><source>Medicinski razgledi (Supplement)</source><rights>InC</rights><subject language_type_id="slv">cepiva</subject><subject language_type_id="slv">holesterol</subject><subject language_type_id="slv">LDL</subject><subject language_type_id="slv">PCSK9</subject><subject language_type_id="slv">primarna preventiva</subject><subject language_type_id="slv">živalski modeli</subject><title>Vaccines directed against proprotein convertase subtilisin/kexin type 9</title></Record>